Basel, Basel, Switzerland
Molecular biologist with 9+ years of experience spanning research, business development, and enterprise software in life sciences. Fluent in English, French, Spanish, and Italian, with working proficiency in German. Currently, I work with global biopharma teams on Genedata Biologics, an enterprise SaaS platform supporting end-to-end biologics discovery and development. My role sits at the intersection of science, customer engagement, and commercial strategy across key accounts in Europe. Previously, I led business development activities for a life sciences portfolio across Europe, APAC, and North America, with a focus on bioinformatics and digital research solutions. Before that, I worked as a research scientist, contributing to published research in genomics and transcriptional regulation. I’m drawn to roles where scientific understanding and commercial thinking come together, particularly in partnerships, strategic accounts, and strategy within complex international environments.
Genedata Biologics is an enterprise software platform enabling end-to-end discovery and engineering of complex biotherapeutics, helping biopharma organizations accelerate and standardize data-driven decision-making across discovery workflows. I partner with customers to translate scientific and operational needs into effective digital solutions, working with technical, commercial, and legal teams to drive long-term value.
• Enable global growth across five business units by shaping and advancing strategic commercial opportunities through cross-functional collaboration with marketing and sales. • Contribute to the development and progression of commercial opportunities from initial engagement through strategic evaluation and opportunity development. • Develop frameworks and digital tools to enhance performance tracking and support data-driven decision-making across key commercial activities.
Frontiers is one of the largest open-access publishers, with a global portfolio of peer-reviewed journals across multiple scientific disciplines. • Developed peer-reviewed journals within a $21M life science portfolio, expanding global engagement in bioinformatics and computational biology research • Generated +$1.5M via BD activities including partnerships, strategic stakeholder engagement, ecosystem development, & performance optimization • Led an international team of 3 specialists
• Supported the growth of a $19M molecular biosciences program by developing and scaling scientific collaborations across industry and academic stakeholders • Contributed to go-to-market strategy & positioning for biosciences portfolio offerings • Mentored a team of 6 specialists and coordinated an internal network of 80+ participants
• Launched 2 life sciences journals & engaged with 250+ KOLs in high-growth segments • Contributed to lifecycle strategy for 8 assets in genomics, & cell and gene therapy • Identified 30+ expansion opportunities via market, SWOT, & competitor analysis
Focused period dedicated to professional skill development and family. • Obtained a B1 German language certification - grade: 82/100 • Courses on strategic thinking, negotiation, interpersonal skills • Relocated to Basel at the end of 2025
Contributed to a $0.8M project on chromosome formation & transcriptional regulation • Co-authored 2 scientific publications - Nucleic Acids Research & PLOS Genetics • Engineered +40 CRISPR strains, improved cloning efficiency 50% & turnaround by 33% • Techniques: molecular cloning, ChIP-seq, qPCR, RNA-seq, NGS, flow cytometry, etc.
Fermentation USP for a proprietary bacterial strain used to produce Broncho‑Vaxom • Analyzed metabolic & process performance indicators summarized in internal reports. • Optimized growth conditions during early-stage culture scale-up from 5 mL to 100 mL • Maintained accurate experimental documentation in accordance with internal SOPs.